Curry’s ability to fight cancer put to the test
A chemical found in curry is to be tested for its ability to kill bowel cancer tumours in patients. Curcumin, which is found in the spice turmeric, has been linked to a range of health benefits. Studies have already shown that it can beat cancer cells grown in a laboratory and benefits have been suggested in stroke and dementia patients as well. Now a trial at hospitals in Leicester will be investigating giving curcumin alongside chemotherapy drugs. About 40,000 people are diagnosed with bowel cancer in the UK each year.
If the disease spreads around the body, patients are normally given a combination of three chemotherapy drugs, but about half will not respond. Forty patients at Leicester Royal Infirmary and Leicester General Hospital will take part in the trial, which will compare the effects of giving curcumin pills seven days before starting standard chemotherapy treatment. Prof William Steward, from Leicester University, who is leading the study, said animal tests combining the two were "100 times better" than either on their own and that had been the "major justification for cracking on" with the trial. He said: "Once bowel cancer has spread it is very difficult to treat, partly because the side effects of chemotherapy can limit how long patients can have treatment.
"The prospect that curcumin might increase the sensitivity of cancer cells to chemotherapy is exciting because it could mean giving lower doses, so patients have fewer side effects and can keep having treatment for longer. "This research is at a very early stage, but investigating the potential of plant chemicals to treat cancer is an intriguing area that we hope could provide clues to developing new drugs in the future." Joanna Reynolds, from Cancer Research UK, said: "By doing a clinical trial like this, we will find out more about the potential benefits of taking large amounts of curcumin, as well as any possible side effects this could have for cancer patients."
--
Advertise with us! Call (Trinidad) (868) 297-2500 (Guyana) (592) 609-3084 - or email pellaumagazine@gmail.com for more info! Also visit http://pellau.tk
Dexter Tittil
General Manager
Pellau Group
http://www.pellau.tk
On Wed, 9 May 2012 21:28:06 -0400, Dexter Tittil wrote:
>
>
> Thursday, May 10, 2012
>
>
>
> from The Trinidad Guardian Newspaper http://www.guardian.co.tt/lifestyle/2012-05-09/curry%E2%80%99s-ability-fight-cancer-put-test
>
Business owners Sign up here for Free
Can You Have More Sales, Too?
Helping over 120,000+ businesses like yours raise profits and build customer relationships using AWeber's opt-in email marketing software for over 10 years.
Trending Articles This Week
-
by: Janine Awai So the countdown has begun and Carnival is in the air. With the countless cooler parties, upcoming fetes and various lim...
-
News 1 new result for pop music Review: Prince live at Hop Farm Worksop Today "THIS is REAL music," squawks Prince to the elati...
-
(become a fan http://www.facebook.com/pages/YOS-Tees/209641012395915 ) Click image above to play :) Its $89 for one (LIMITED TIME P...
-
Rachelle Marcial 1) What/who inspired you to get into modeling? My best friend Crystal Hamilton encouraged me to take up modeling whe...
-
News 3 new results for r&b Vigilance books R&B Executive Engineer, others Kashmir Dispatch "Mohammad Shafi Bhat Executive E...
-
Sheets Energy Strips are available nationwide! Sheets are the calorie free way to get an instant boost of energy! Become a fan on facebook t...
-
Good Gryffindor ... already!? Less than a year after the release of Deathly Hallows Part 2 , is Daniel Radcliffe prepping for a potential...
-
Blogs 5 new results for hollywood Academy - The Hollywood Reporter By Gregg Kilday The Academy of Motion Picture Arts and Sciences hasn...
-
News 3 new results for fashion Nicole Richie to team up with Jessica Simpson on NBC's ' Fashion Star' CNN (PEOPLE.com) -- Sh...
-
Nicky B is “thrilled” about his 2011 EME nomination AGSelectPR, KINGSTON, Monday, February 21st 2011: Nicky B ended 2010 on a high note,...
Disclaimer
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.







0 comments:
Post a Comment